Gilead Sciences Signs Licensing Deals With 6 Drugmakers to Manufacture HIV Prevention Drug Lenacapavir
Is Viatris Inc. (VTRS) the Best Stock Under $15 To Buy Now?
Viatris Launches Viagra ODF in Canada, A New Dissolvable Erectile Dysfunction Treatment
Express News | Viatris Launches (Pr)Viagra® Odf in Canada: A New Oral Dissolving Film Form of the Erectile Dysfunction Treatment
Express News | Viatris Inc - Under Revolving Credit Facility Co May Obtain Extensions of Credit in Aggregate Principal Amount Not to Exceed $3.5 Bln
Express News | Viatris Inc - Entered Into Second Amended and Restated Revolving Credit Agreement
Piper Sandler Maintains Viatris(VTRS.US) With Hold Rating, Maintains Target Price $13
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024
Express News | Viatris Inc: Pricing Terms for Outstanding 1.650% Senior Notes Due 2025 Issued by Viatris & Outstanding 2.125% Senior Notes Due 2025 Issued by Mylan
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma
Express News | Viatris Announces Cash Tender Offers for Certain Outstanding Notes
Press Release: Viatris Announces Cash Tender Offers for Certain Outstanding Notes
China has identified a new lineage of monkeypox for the first time. Experts believe that the likelihood of a large-scale outbreak of monkeypox in China is low.
On September 3rd, according to Beijing Daily, a Chinese research team recently published a new study in the international medical journal Nature Communications: for the first time, they identified the new lineage of monkeypox C.1.1.
Viatris Insider Sold Shares Worth $1,195,075, According to a Recent SEC Filing
Express News | The World Health Organization has launched a global strategy preparedness and response plan to contain the spread of monkeypox epidemic.
Viatris(VTRS.US) Director Sells US$3.52 Million in Common Stock
$Viatris(VTRS.US)$ Director Malik Rajiv sold 300K shares of common stock on Aug 21, 22, 23, 2024 at an average price of $11.7433 for a total value of $3.52 million.Source: Announcement What is
Viatris Says Late-breaking Oral Presentation Shows That Cenerimod For Systemic Lupus Erythematosus In Japanese Patients Can Be Considered Safe And Well-tolerated
Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress